
Keywords: PM, Personalized medicine; AD, Autoimmune disease; RA, Rheumatoid Arthritis; T1D, Type 1 Diabetes Mellitus; ACPA, anti-citrullinated peptides antibodies; RF, rheumatoid factor; DMARD, disease-modifying antirheumatic drug; HAQ, Health Assessment Questionna